RedHill Biopharma Gross Profit Growth & History (RDHL)

RedHill Biopharma's gross profit was $4.9M for fiscal 2024.

View full RedHill Biopharma company overview

RedHill Biopharma annual gross profit history

RedHill Biopharma annual gross profit

Fiscal yearPeriod endedGross profitChangeGrowth
20242024-12-31$4.9M$1.8M+57.96%
20232023-12-31$3.1M−$25.4M−89.21%
20222022-12-31$28.5M−$7.9M−21.70%
20212021-12-31$36.4M$8.9M+32.34%
20202020-12-31$27.5M$23.4M+581.23%
20192019-12-31$4.0M−$1.5M−27.00%
20182018-12-31$5.5M$3.6M+193.62%
20172017-12-31$1.9M$1.8M+1762.38%
20162016-12-31$101,000$98,000+3266.67%
20152015-12-31$3,000

RedHill Biopharma gross profit trends

Over the last five fiscal years, RedHill Biopharma's gross profit increased from $4.0M to $4.9M, a change of $819,000. The latest reported quarter, Q2 2022, shows $9.4M.

About the metric

What gross profit means

Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.

Calculation and source

SEC-reported and calculated gross profit

TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RedHill Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about RDHL yet. Start the conversation.

Write the first post